Key result
The new generation Ankura thoracic stent graft demonstrated safety and user-friendliness in an initial experience treating two patients with acute aortic syndrome.
Why the study?
Is the new generation Ankura thoracic stent graft safe and user-friendly for the treatment of acute aortic syndrome?
Is the new generation Ankura thoracic stent graft safe and user-friendly for the treatment of acute aortic syndrome?
Initial experience suggests the new generation Ankura thoracic stent graft is a safe and user-friendly endovascular treatment option for acute aortic syndrome.
Hypothesis-generating for the Ankura device in acute aortic syndrome; larger prospective trials needed before practice change.
Initial experience with the new generation thoracic endograft (Ankura, Lifetech) in acute aortic syndrome was encouraging. The device was both user‐friendly and safe and it will increase the armamentory of the available endovascular treatment options.
No takes yet. Share an insight, caveat, or question.
Kratimenos et al. (2021) studied this question. The new generation Ankura thoracic stent graft demonstrated safety and user-friendliness in an initial experience treating two patients with acute aortic syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: